
January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.

January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.

Applied Clinical Trials
How the use of M&S in cancer trials from the outset can help address those critical “what if?” scenarios and accelerate oncology drug development.

September 1st 2018